SAW | Jotup

NanoVibronix Announces Commencement of UroShield Clinical Study at the University of Michigan

Retrieved on:

Mittwoch, Mai 22, 2024

Research, Medical Devices, Clinical Trials, Health Technology, Biotechnology, Health, University, Science, Education, Patient, SAW, Clinical trial, FDA, Urinary tract infection, Clinical study design, Quality of life, Pharmaceutical industry

NanoVibronix, Inc. (Nasdaq: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that the University of Michigan will begin the pilot phase of its clinical trial of UroShield this week.

Key Points:

NanoVibronix, Inc. (Nasdaq: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that the University of Michigan will begin the pilot phase of its clinical trial of UroShield this week.
The “pilot” phase of the study is the first component of the broader study.
As previously announced on November 28, 2023, the company signed a Research Agreement with the Regents of the University of Michigan for a Randomized Control Trial (“RCT”) study of UroShield to further advance clinical evidence of the efficacy of UroShield.
Brian Murphy, Chief Executive Officer of NanoVibronix, Inc., said, “Entering into the pilot phase of the UroShield study at the University of Michigan is an important step towards our goal of applying for permanent FDA clearance or approval for the UroShield product.

NanoVibronix Issues Letter to Stockholders

Retrieved on:

Donnerstag, Mai 16, 2024

We are focused on several areas that we believe will have a substantial impact on our growth and product adoption.

Key Points:

We are focused on several areas that we believe will have a substantial impact on our growth and product adoption.
Many of these areas of focus have begun showing positive results, as reflected in our most recent quarterly financial results.
Our balance sheet remains strong with approximately $2.7 million of cash and inventory of approximately $2.6 million.
Our penetration into the Veterans Affairs (“VA”) continues to improve both in facilities served as well as adoption within those facilities.

NanoVibronix Announces Distribution Agreement with VA Supplier CB Medical for the Distribution of UroShield

Retrieved on:

Dienstag, Mai 14, 2024

NanoVibronix, Inc. (Nasdaq: NAOV) (“NanoVibronix,” or the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has entered into a distribution agreement with CB Medical, LLC (“CB Medical”) for the sale and distribution of the Company’s UroShield.

Key Points:

NanoVibronix, Inc. (Nasdaq: NAOV) (“NanoVibronix,” or the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that it has entered into a distribution agreement with CB Medical, LLC (“CB Medical”) for the sale and distribution of the Company’s UroShield.
CB Medical is a U.S. Department of Veteran Affairs (“VA”) certified and Service-Disabled Veteran-Owned Small Business (“SDVOSB”) with two decades of experience serving veterans.
Under the terms of the multi-year agreement, CB Medical has the right to sell and distribute UroShield to its customers throughout the VA system in the United States.
Brian Murphy, Chief Executive Officer of NanoVibronix, Inc., commented, "This new agreement provides us with another distribution channel for UroShield within the VA system of providers.

NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs’ FSS Contract Award

Retrieved on:

Mittwoch, Mai 1, 2024

Medical Devices, Veterans, Defense, Health, Health Technology, Pain, Health care, Partnership, Government, Acquisition, SAW, SDVOSB, FSS, Veteran, Medical imaging

Delta Medical, LLC, a service-disabled veteran-owned small business (“SDVOSB”) and distributor of the Company’s PainShield product (“Delta Medical”), was awarded a five-year FSS contract by the VA, that includes the Company’s PainShield product.

Key Points:

Delta Medical, LLC, a service-disabled veteran-owned small business (“SDVOSB”) and distributor of the Company’s PainShield product (“Delta Medical”), was awarded a five-year FSS contract by the VA, that includes the Company’s PainShield product.
Brian Murphy, Chief Executive Officer of the Company commented, “As the largest integrated health care network in the U.S., the VA represents a massive opportunity for the placement of our PainShield devices.
The VA serves nine million enrolled veterans each year and including our PainShield product in the FSS will help the VA meet its healthcare acquisition needs.
We are excited for this new chapter in our partnership with NanoVibronix and the VA community as a whole.”

RF Filter Market Size to Grow USD 48.1 Billion by 2031 at a CAGR of 16.6% | Valuates Reports

Retrieved on:

Donnerstag, April 25, 2024

The Global RF filter market was valued at USD 10.5 Billion in 2021, and is projected to reach USD 48.1 Billion by 2031, growing at a CAGR of 16.6% from 2022 to 2031.

Key Points:

The Global RF filter market was valued at USD 10.5 Billion in 2021, and is projected to reach USD 48.1 Billion by 2031, growing at a CAGR of 16.6% from 2022 to 2031.
Thirdly, the market is expanding due to the growing need for RF filters in defense and aerospace applications, such as radar systems and satellite communications.
Furthermore, improvements in RF filter technologies, such bulk acoustic wave (BAW) and surface acoustic wave (SAW) filters, are expanding their market acceptance and increasing their usefulness.
The market for RF filters is expanding significantly due to the widespread use of mobile phones for communication.

RF Filter Market Size to Grow USD 48.1 Billion by 2031 at a CAGR of 16.6% | Valuates Reports

Retrieved on:

Donnerstag, April 25, 2024

The Global RF filter market was valued at USD 10.5 Billion in 2021, and is projected to reach USD 48.1 Billion by 2031, growing at a CAGR of 16.6% from 2022 to 2031.

Key Points:

The Global RF filter market was valued at USD 10.5 Billion in 2021, and is projected to reach USD 48.1 Billion by 2031, growing at a CAGR of 16.6% from 2022 to 2031.
Thirdly, the market is expanding due to the growing need for RF filters in defense and aerospace applications, such as radar systems and satellite communications.
Furthermore, improvements in RF filter technologies, such bulk acoustic wave (BAW) and surface acoustic wave (SAW) filters, are expanding their market acceptance and increasing their usefulness.
The market for RF filters is expanding significantly due to the widespread use of mobile phones for communication.

Torque Sensors Market Size to Grow USD 11810 Million by 2029 at a CAGR of 4.5% | Valuates Reports

Retrieved on:

Donnerstag, April 25, 2024

Vehicle, Internet of things, MEMS, Element, Safety, Torque, Automotive industry, Automation, SAW, Robotics, Feedback, Aircraft, Government, Defense, Electric motor

BANGALORE, India, April 25, 2024 /PRNewswire/ -- Torque Sensors Market is Segmented by Type ( Reaction Torque Sensor , Rotary Torque Sensor , Super Acoustic Wave (SAW) Torque Sensor, Optical Torque Sensor ), by Application (Automotive, Manufacturing, Aerospace and Defense, Healthcare)

Key Points:

BANGALORE, India, April 25, 2024 /PRNewswire/ -- Torque Sensors Market is Segmented by Type ( Reaction Torque Sensor , Rotary Torque Sensor , Super Acoustic Wave (SAW) Torque Sensor, Optical Torque Sensor ), by Application (Automotive, Manufacturing, Aerospace and Defense, Healthcare)
The Global Torque Sensors Market size is expected to reach US$ 11810 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029.
The market for torque sensors is expanding rapidly thanks to a number of important considerations.
Second, the market is expanding due to strict government laws requiring the usage of torque sensors for safety and quality assurance.
The need for torque sensors is also being driven by the increased emphasis on predictive maintenance and real-time machinery monitoring to maximize operational efficiency.

Torque Sensors Market Size to Grow USD 11810 Million by 2029 at a CAGR of 4.5% | Valuates Reports

Retrieved on:

Donnerstag, April 25, 2024

Vehicle, Internet of things, MEMS, Element, Safety, Torque, Automotive industry, Automation, SAW, Robotics, Feedback, Aircraft, Government, Defense, Electric motor

BANGALORE, India, April 25, 2024 /PRNewswire/ -- Torque Sensors Market is Segmented by Type ( Reaction Torque Sensor , Rotary Torque Sensor , Super Acoustic Wave (SAW) Torque Sensor, Optical Torque Sensor ), by Application (Automotive, Manufacturing, Aerospace and Defense, Healthcare)

Key Points:

BANGALORE, India, April 25, 2024 /PRNewswire/ -- Torque Sensors Market is Segmented by Type ( Reaction Torque Sensor , Rotary Torque Sensor , Super Acoustic Wave (SAW) Torque Sensor, Optical Torque Sensor ), by Application (Automotive, Manufacturing, Aerospace and Defense, Healthcare)
The Global Torque Sensors Market size is expected to reach US$ 11810 million by 2029, growing at a CAGR of 4.5% from 2023 to 2029.
The market for torque sensors is expanding rapidly thanks to a number of important considerations.
Second, the market is expanding due to strict government laws requiring the usage of torque sensors for safety and quality assurance.
The need for torque sensors is also being driven by the increased emphasis on predictive maintenance and real-time machinery monitoring to maximize operational efficiency.

NanoVibronix Issues Letter to Stockholders

Retrieved on:

Dienstag, April 9, 2024

We are focused on several areas that we believe will have a substantial impact on our growth and product adoption.

Key Points:

We are focused on several areas that we believe will have a substantial impact on our growth and product adoption.
A driving factor in our increased revenues was increased sales to customers using the Veterans’ Health System and worker’s compensation plans.
On our balance sheet for the period ended December 31, 2023, we had $3.3 million of cash and inventory of $2.7 million.
CMS invited NanoVibronix to a public meeting to present its findings and to answer CMS’s questions, which was held June 1, 2023.

NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield

Retrieved on:

Donnerstag, März 28, 2024

Medical Devices, Health, Health Technology, Research, Science, Biotechnology, SAW

NanoVibronix, Inc. (Nasdaq: NAOV) (“NanoVibronix” or the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has entered into an agreement with Veranex, Inc. (“Veranex”) to assist with the development of the company’s next generation UroShield and PainShield products.

Key Points:

NanoVibronix, Inc. (Nasdaq: NAOV) (“NanoVibronix” or the “Company”), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced it has entered into an agreement with Veranex, Inc. (“Veranex”) to assist with the development of the company’s next generation UroShield and PainShield products.
Under the terms of the agreement, Veranex will provide certain research and development services as related to PainShield and UroShield.
Brian Murphy, Chief Executive Officer of NanoVibronix, Inc., said, “Teaming up with Veranex provides us with access to additional industry expertise and manufacturing know-how to further improve our products and stay ahead of the innovation curve.
By working with an outside partner with proven methods and techniques to evolve our products, we believe we will be able to offer a next generation of products that not only increases clinician and patient satisfaction but also future-proofs the components and reduces our cost of goods.”